Duke Capital Limited has completed a fundraising
Duke Capital Limited has completed a successful fundraise, securing US$29.8 million (£23.5 million) through a placing and retail offer on the Alternative Investment Market (AIM). This milestone will further enable Duke Capital to continue its innovative approach to alternative financing solutions for small and medium enterprises (SMEs) across the UK and Europe.
Duke Capital delivers hybrid capital solutions to SME business owners in the UK, Europe and North America, combining the best features of both equity and debt. Since 2017, Duke Capital has provided unique long-term financing which eliminates refinancing risk and the need for a short-term exit. This is achieved through a distinctive “corporate mortgage,” while also aligning its returns to grow with the success of the business.
Oaklins Cavendish, one of Oaklins’ member firms in the UK, supported Duke Capital in this recent fundraise.
Talk to the deal team
Related deals
Danish leader in access control systems has been sold to Vækst-Invest
Unitek, a leading provider of innovative access control systems in Denmark, has been acquired by the Danish private equity firm Vækst-Invest to drive its growth and expansion.
Learn moreAcapo AS has been acquired by Longship AS
Oslo-based intellectual property advisory firm Onsagers, supported by Longship since May 2024, has acquired Acapo AS. By combining decades of expertise and global reach, this strategic acquisition unites two of Norway’s most reputable IP firms, enabling them to offer a comprehensive range of solutions in patents, trademarks and IP strategy. This milestone strengthens their position in building a best-in-class network for strategic IP management, marking a key step in their continued growth.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn more